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Abstract
Aim: To compare the diagnostic yield of small intestinal contrast ultrasonography
(SICUS) with magnetic resonance enterography (MRE) in routine clinical practice in
a cohort of pediatric patients investigated for Crohn’s disease (CD) attending a UK
tertiary center.
Methods and Results: Patients with suspected or established CD who underwent
SICUS were identiﬁed retrospectively. SICUS was compared to conventional trans-
abdominal ultrasound (TUS), ileocolonoscopy (IC), and MRE. The accuracy and
agreement of SICUS in detecting small bowel lesions and CD-related complications
were assessed using kappa (κ) coefﬁcient statistics. A total of 93 patients (median age
15 years, range 2–17, 49 male) underwent SICUS; 58 had suspected and 35 had
established CD. In suspected CD, sensitivity and speciﬁcity of SICUS in detecting
CD small bowel lesions were 81.8 and 100% and for TUS 85.7 and 87.5%, respec-
tively. In established CD, sensitivity and speciﬁcity of SICUS were 98.7 and 100%
and TUS 80 and 100%, respectively. Agreement between SICUS and IC was substan-
tial for the presence of lesions (κ = 0.73) but fair in TUS (κ = 0.31). Agreement
between SICUS and IC was almost perfect for detecting strictures (κ = 0.84), with a
sensitivity of 100% and speciﬁcity of 97.6%. When comparing SICUS and TUS with
MRE, agreement for the presence of lesions was substantial (κ = 0.63) and moderate
(κ = 0.53), respectively. Agreement between SICUS and MRE was substantial for
detecting strictures (κ = 0.77) and dilatation (κ = 0.68).
Conclusions: SICUS offers a radiation-free alternative for assessing pediatric small
bowel CD, with diagnostic accuracy that is comparable to MRE and IC, supporting
its wider use in routine practice.
Introduction
Crohn’s disease (CD) occurs in approximately four children per
100 000 in Europe and North America, and its incidence is
rising.1–3 CD affects the small bowel in as many as two thirds of
pediatric cases.4 Diagnosis is often difﬁcult as children may not
present with the classical triad of diarrhea, pain, and weight loss.5
Delays in diagnosis and treatment can lead to growth retardation
and pubertal delay, often advanced by the time a diagnosis is
made.6,7 There is also an increased risk of developing complica-
tions such as intestinal strictures and ﬁstulae.8–10
The relapsing nature of CD necessitates intermittent, but
lifelong, radiological assessment, commonly undertaken in the
past with small bowel follow-though (SBFT) and CT entero-
graphy.11,12 However, retrospective studies have conﬁrmed that
both adults and children with CD may have high levels of cumu-
lative exposure to diagnostic ionizing radiation, drawing attention
to the need for alternative, accurate, radiation-free techniques.
13–17 In view of this, magnetic resonance enterography (MRE) is
now more frequently used to assess pediatric CD, providing an
accurate tool to assess disease extent and distribution, depicting
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both intestinal and extraintestinal disease-related complications.18
It is favored due to its inherent multiplanar capability and ability
to provide excellent soft-tissue contrast resolution without expo-
sure to ionizing radiation.19 However, it is expensive, time-con-
suming, and sometimes poorly tolerated, particularly in children
who may not be able to lie still during the procedure without a
general anesthetic.
Transabdominal ultrasound (TUS) has been used to evalu-
ate small bowel CD in both children and adults but may be ham-
pered by the presence of endoluminal gas, which can obscure
pathology.20,21 Administering oral contrast before performing
abdominal ultrasound distends the small bowel and improves
bowel wall visualization. Studies have validated small intestinal
(oral) contrast-enhanced ultrasonography (SICUS) in evaluating
adults with CD,22–25 but very few studies in children, for whom
this imaging technique is well suited, have been published, and
none have evaluated its use in routine clinical practice.26,27 Here,
we describe our 5-year experience of SICUS in routine clinical
practice, introduced as part of service improvement at a single
regional referral center, retrospectively comparing its diagnostic
accuracy to conventional TUS, MRE, and ileocolonoscopy
(IC) in evaluating children and adolescents with suspected or
established CD.
Methods
The study protocol was approved by the hospital’s local ethics
and research and development committees as part of an ongoing
local audit of service development. Patient conﬁdentiality was
maintained through the anonymization of collected data. We
followed the Standards for Reporting of Diagnostic Accuracy
(STARD) criteria for reporting studies considering diagnostic
accuracy.28
Study design and setting. Since January 2009, SICUS
has been available for children and adolescents with signs and
symptoms of small intestinal disease, in addition to conventional
investigations, and has been performed at the discretion of the
responsible clinician. We retrospectively identiﬁed all patients
younger than 18 years of age who had been assessed by SICUS
between January 2009 and December 2013 from the radiology
information system database, cross-referenced with the ultra-
sound department’s booking diary to ensure a comprehensive
dataset. We also determined which of these patients with CD
underwent bowel resection within 6 months of undergoing
SICUS or MRE from electronic patient records. Their surgical
notes were reviewed along with TUS, IC, and MRE reports, per-
formed within 6 months of the SICUS study (Fig. 1). We col-
lated demographic data, C-reactive protein (CRP), erythrocyte
sedimentation rate (ESR), and fecal calprotectin (FC) within
2 weeks of each imaging investigation as surrogate markers of
disease severity. Radiological ﬁndings were compared to assess
the accuracy and agreement of SICUS in diagnosing CD and its
related complications, including proximal dilatation.
Features of CD. A diagnosis of small bowel CD was
entertained if SICUS detected one or more of the following fea-
tures in the context of a consistent clinical presentation:
(i) increased bowel wall thickness ≥ 3 mm; (ii) absence of
peristalsis; (iii) stiffened bowel loop, deﬁned as an intestinal loop
that remained unchanged during transabdominal compression
with the ultrasound probe; (iv) presence of a stricture, ﬁstula, or
abscess; (v) absence of wall stratiﬁcation; (vi) increased mural or
mesenteric power Doppler (vascular) activity; (vii) mesenteric
lymph node hypertrophy; and (viii) fat creep caused by mesen-
teric fat hypertrophy.22
Radiology
Small intestinal contrast ultrasonography. After a 6-h fast,
a baseline ultrasound of the abdomen and pelvis was performed
using either an Aplio XG (Toshiba Medical Systems, Tochigi,
Japan) with a 1.5–6 MHz curvilinear array or a Logic
9 (GE Healthcare, Milwaukee, WI, USA) with a 2–5 MHz curvi-
linear array to assess for any solid visceral pathology that might
explain the patient’s presenting symptoms. Initial small bowel
evaluation was also undertaken, looking for any areas of bowel
wall thickening, loss of normal wall stratiﬁcation, or mesenteric
thickening, using a combination of high-frequency curvilinear
and linear transducers (3–9 and 6–11 MHz on the Aplio and
4–12 MHz on the Logic 9). The patient then consumed the con-
trast medium: pediatric formulation polyethylene glycol
(Movicol). Each sachet of contrast medium was dissolved in
250 mL tap water in preparation for SICUS. For children
weighing less than 50 kg, one to three sachets, according to their
weight, were used at the discretion of the radiologist; otherwise,
four sachets were used. Intermittent scans were then performed
over the next 30 min or until the solution had moved through to
the distal ileum. Features of the small bowel were conﬁrmed by
its location, mucosal fold pattern, and its motility. Adjacent
bowel loops were displaced by graded compression, and this also
permitted bowel wall stiffness to be determined. Power Doppler
was used to assess intramural and adjacent mesenteric vascularity
when considering abnormal loops of the small bowel. For both
ultrasound systems, the parameters were optimized toward low-
Figure 1 Flow diagram showing the investigations that the study
cohort underwent. CD, Crohn’s disease; MRE, magnetic resonance
enterography; SICUS, small intestine contrast-enhanced ultrasonogra-
phy; TUS, transabdominal ultrasound.
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volume ﬂow while trying to avoid excessive ﬂash artifact. A
pulse repetition frequency (PRF) of 800 Hz was used, with a low
to medium wall ﬁlter, and the gain was adjusted to just below
the noise ﬂoor. Scans were performed or supervised by two expe-
rienced radiologists with a subspecialty interest in ultrasonogra-
phy (JP and RA).
Magnetic resonance enterography. Scans were performed
using a Siemens 1.5T scanner (Siemens UK, Frimley, Surrey, UK)
with an eight-channel body coil. All patients attended 90 min prior
to the scan and were asked to drink an oral contrast mix comprising
1 L of water (to ﬁll the bowel), four scoops of Vitaquick thickener,
and 5 mg of metoclopramide hydrochloride. Patients were
instructed to drink the ﬁrst cup quickly and the remainder gradually
over 45 min. A drug history was taken to verify that there were no
contraindications to the antimuscarinic hyoscine butylbromide
(Buscopan), given to reduce intestinal motility. Patients and/or their
parents were also made aware of the potential adverse effects of
mannitol and asked to empty their bladder prior to scanning.
Patients were positioned prone to reduce peristalsis and
the number of imaging slices required. The following three
sequences were obtained to image the entire small bowel:
localizers, coronal 2D FIESTA, coronal T2 Fat Sat, coronal lava,
Axial T2, coronal lava postcontrast 30 s, coronal lava post-
contrast 70 s, and axial lava postcontrast. Coronal T2 fat satura-
tion and axial lava were also acquired to image the terminal
ileum exclusively. MRE was reported by JV and other members
of the department.
Statistical analysis. The sensitivity and speciﬁcity of
SICUS in identifying CD were calculated according to the ﬁnal
clinical diagnosis (gold standard), determined by the treating gas-
troenterologist, taking into account clinical history, examination
ﬁndings, biochemical results, and imaging ﬁndings other than
those of SICUS. Consistency between investigations was tested
by Cohen’s kappa coefﬁcient statistical analysis (κ), with 0–0.20
indicating slight agreement, 0.21–0.40 fair, 0.41–0.60 moderate,
0.61–0.80 substantial, and 0.81–1 almost perfect agreement.
CRP, ESR, and FC were compared using a paired Student’s t-test.
Results
A total of 93 patients underwent SICUS during the study period
(median age 15 years, range 2–17, 49 male), with 58 having
suspected and 35 established CD. Figure 2 illustrates small bowel
complications identiﬁed by SICUS and MRE in a representative
patient with CD.
SICUS versus MRE. Seventeen patients were assessed with
both SICUS and MRE (median age 15.1 years, range 8–17,
10 male). No difference was found in markers of disease severity
at the time of each radiological investigation, SICUS (CRP
24.4  33.3, ESR 21.1  22.8, FC 514.8  830.5), and MRE
(CRP 19.1  18.4, ESR 26.9  18.5, FC 1266.6  1070.6);
P = 0.18, 0.92, and 0.18, respectively. The mean interval
between SICUS and MRE was 108.9 days  SD 54.5. Compara-
tive statistical data are provided in Table 1. Agreement between
TUS and MRE was moderate (κ = 0.53) for the presence of
lesions but substantial between SICUS and MRE (κ = 0.63). In
our cohort, SICUS correctly identiﬁed 3 of 4 proximal bowel
lesions, and 9 of 10 distal small bowel lesions were detected by
MRE. Agreement between SICUS and MRE was substantial in
detecting both strictures (κ = 0.77) and dilatation (κ = 0.68).
SICUS identiﬁed two cases of small dilatation not identiﬁed
by MRE.
Figure 2 A 16-year-old male with Crohn’s disease. (a) Coronal mag-
netic resonance enterography (MRE), gradient Echo (GRE) sequence
(2D FIESTA), demonstrating bowel wall thickening affecting the termi-
nal ileum, caecum, and appendix. (b) Coronal MRE, 3D, T1-weighted
sequence with fat suppression and intravenous gadolinium contrast
administration (LAVA) at 70s postinjection, demonstrating avid
enhancement of the thickened segment of bowel. (c) Selected small
intestinal contrast ultrasonography (SICUS) images demonstrating the
same loop of terminal ileum, with bowel wall thickening and edema
(hypoechoic change), decreased luminal diameter, and (d) increased
vascularity on Doppler imaging.
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TUS versus SICUS. When comparing sonographic ﬁndings
before and after contrast administration, the sensitivity and speci-
ﬁcity of detecting CD small bowel lesions in those with
suspected disease were 85.7 and 87.5% for TUS and 98.7 and
100% for SICUS, respectively. In patients with known CD, sen-
sitivity and speciﬁcity of TUS were 80.0 and 100% and 97.3 and
100% for SICUS, respectively.
SICUS versus IC. Thirty-nine patients were evaluated with
both TUS/SICUS and IC, with a mean interval of 89.7 days  SD
76.5 between investigations. Inﬂammatory markers at the time of
SICUS (CRP 24.4  33.3, ESR 21.1  22.8, FC 514.8  830.5)
and IC (CRP 21.1  31.8, ESR 26.9  23.3, FC 686.6  949.4)
were not signiﬁcantly different (P = 0.39, 0.18 and 0.77, respec-
tively). Agreement between SICUS and TUS with IC for the
presence of terminal ileal lesions was substantial (κ = 0.73, 95%
CI 0.43–1.0) and fair (κ = 0.31, 95% CI 0.09–0.71), respectively.
Agreement between SICUS and IC was almost perfect for
detecting strictures (κ = 0.84, 95% CI 0.54–1), with 100% sensi-
tivity and 97.5% speciﬁcity.
SICUS versus surgery. Three patients underwent resective
bowel surgery, all within 2 months of SICUS evaluation (range
24–60 days). At surgery, terminal ileal disease and wall thicken-
ing was noted in all three cases, corroborating SICUS ﬁndings.
In one patient, a 5 cm ileocolonic stricture was present at opera-
tion, and in another, a colovesical ﬁstula was identiﬁed; SICUS
correctly delineated both CD-related complications.
Discussion
As clinical symptoms and signs may lag behind intestinal muco-
sal disease activity in CD, disease monitoring using biochemical
markers, cross-sectional imaging, and endoscopy is impor-
tant.29,30 This approach aims to identify subclinical disease to
allow timely diagnosis and medical therapy and to monitor
mucosal response to treatment with the aim of reducing the need
for surgery. However, the requirement for more frequent imaging
increases the potential risks of a high cumulative exposure to ion-
izing radiation for the patient when performing small bowel bar-
ium studies and CT imaging; this is particularly relevant in
children and adolescents amongst whom there is a rising inci-
dence.2,31 MRE has therefore emerged as the preferred imaging
technique in evaluating small bowel CD as it avoids this while
offering high sensitivity and speciﬁcity in diagnosing CD.32 Its
drawback is a lack of availability, high relative cost, and difﬁ-
culty performing it in young children who may be unable to lie
still during image acquisition without a general anesthetic. Our
study, the ﬁrst to compare the use of SICUS with MRE in rou-
tine clinical practice in a pediatric cohort, suggests that SICUS
offers a satisfactory alternative with comparable diagnostic yield.
Agreement between SICUS and MRE was substantial for
detecting small bowel lesions (κ = 0.63) and stricturing disease
(κ = 0.77). Furthermore, SICUS had near-perfect agreement with
IC in detecting terminal ileal disease (κ = 0.87).
TUS is an inexpensive, readily available option in the
assessment of pediatric CD, with a reported sensitivity of
between 74 and 88%.33–35 Some groups have demonstrated
results comparable to MRE,36,37 but it can fail to detect proximal
small bowel lesions reliably, with reported sensitivity as low as
50%.26 This has led to interest in administering oral contrast
prior to ultrasonography to promote bowel loop distension to
enhance the clarity of visualization of adjacent bowel loops.38 In
our cohort, SICUS proved to be superior in terms of both sensi-
tivity and speciﬁcity when compared to TUS in deﬁning small
bowel lesions.
We found agreement between SICUS and MRE to be sub-
stantial in identifying small bowel lesions, stricturing disease,
and wall dilatation. In a prospective pediatric case series, Pallotta
et al. reported that SICUS correlated well with SBFT in both
identifying small bowel lesions and assessing their length.26
They found the agreement between SICUS and SBFT to be
almost perfect in delineating both distal and proximal disease
(κ = 0.93). In another recent Italian study,27 SICUS had a higher
sensitivity than MRE in detecting jejunal disease (92 vs 75%),
which occurs more commonly in pediatric CD.10 The sensitivity
of MRE was slightly higher than SICUS in detecting lesions of
the proximal and mid ileum (100 vs 80%, respectively) and iden-
tical (94%) for detecting terminal ileal disease. They also
reported that MRE and SICUS were both well tolerated. In our
study, SICUS fared well when compared to MRE with sub-
stantial/almost perfect agreement for both proximal (κ = 0.78)
and distal lesions (κ = 0.87).
While we did not formally assess the tolerability of SICUS
and MRE in this retrospective study, anecdotally, clinicians,
patients, and parents reported that SICUS was well tolerated,
Table 1 Comparing small intestinal contrast ultrasonography with the reference standard of magnetic resonance enterography in pediatric Crohn’s
disease
SICUS
MRE TP FP TN FN Kappa Sensitivity Speciﬁcity
Presence of lesion 11 9 1 5 2 0.63 (0.25–1) 0.82 (0.48–0.97) 0.83 (0.36–0.97)
Site: distal 10 9 0 6 1 0.87 (0.63–1) 0.9 (0.55–0.98) 1 (0.54–1)
Site: proximal 4 3 0 6 1 0.78 (0.39–1) 0.75 (0.20–0.96) 1 (0.54–1)
Stricturing disease 3 2 0 14 1 0.77 (0.34–1) 0.67 (0.12–0.95) 1 (0.77–1)
Site of stricture 3 2 0 14 1 0.77 (0.34–1) 0.67 (0.12–0.95) 1 (0.77–1)
Dilatation 3 3 2 12 0 0.68 (0.26–1) 1 (0.31–1) 0.86 (0.56–0.97)
95% conﬁdence intervals given in brackets.
FN, false negative; FP, faecal calprotectin; MRE, magnetic resonance enterography; SICUS, small intestinal contrast ultrasonography; TN, true
negative; TP, true positive.
Small intestinal contrast ultrasound A Hakim et al.
4 JGH Open: An open access journal of gastroenterology and hepatology (2019) 1–6
© 2019 The Authors. JGH Open: An open access journal of gastroenterology and hepatology published by Journal of Gastroenterology and Hepatology Foundation and
John Wiley & Sons Australia, Ltd.
sometimes better so than MRE. It appeared to be particularly
suited to young patients who may otherwise struggle to lie still
in the enclosed environment of an MR scanner. Indeed, MRE
can be problematic in those under 8 years of age, and a general
anesthetic is often required, which is not always straightforward.
SICUS offers a promising alternative in the very young as it can
be performed using a nasogastric tube without a general anes-
thetic in patients as young as 2 years of age in our cohort.
Our study is limited by its retrospective design, small sam-
ple size, and the fact that it was undertaken in a single regional
center. It is that possible disease progression may have occurred
in the interval between SICUS and other investigations. This was
considered unlikely because the ESR, CRP, and FC, all validated
surrogate markers of disease activity, were not signiﬁcantly dif-
ferent at the time of each investigation.39,40 All SICUS studies
were performed independently by one of three radiologists, but
the retrospective design did not allow assessment of interobserver
variability. Finally, the evaluation of SICUS as part of service
development prevented masking of the multidisciplinary team
from the results, a potential confounder, although SICUS was
usually performed as the ﬁrst investigation. In terms of training
new personnel, it has been established in adults that SICUS per-
formed by an inexperienced ultrasonographer can achieve better
diagnostic accuracy over conventional TUS performed by an
experienced sonographer in the detection of small bowel pathol-
ogy in CD; nevertheless, there is clearly a learning curve.41 We
chose not to reevaluate and rereport MRE images as it was
believed that, ﬁrst, the study aimed to compare SICUS and MRE
in routine clinical practice, and second, because SICUS is a
dynamic test that cannot easily be accurately reported retrospec-
tively without deﬁned and stored cine clips, it would favor MRE
if additional features were identiﬁed on revaluation. Clearly the
small size of this study means our ﬁndings must be interpreted
cautiously. However, this is the ﬁrst study to evaluate SICUS
against MRE in a pediatric cohort in a real-world setting.
In conclusion, our ﬁndings provide preliminary evidence
to suggest that SICUS offers a comparable diagnostic yield to
that of MRE and IC and performed better than TUS in a pediatric
cohort with suspected or established CD. Our work comparing
SICUS and MRE in routine clinical practice adds to the existing,
albeit very limited evidence, that SICUS offers a radiation-free
alternative to MRE for the evaluation of CD in children and ado-
lescents. Our ﬁndings support its wider adoption in this age
group. Further dedicated prospective comparative studies of
SICUS and MRE, such as the United Kingdom-based MR
Enterography or ulTrasound In Crohn’s disease (METRIC) trial
in adults, are now needed in children.42
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